FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot

[cafead]

via The U.S. health regulator has changed its strain recommendation for the 2024-25 COVID-19 vaccines, as it asked manufacturers to update the new shots to target the KP.2 variant, if feasible, instead of the JN.1 lineage it sought to target earlier.

article source